Prosecution Insights
Prosecution Insights
6 pending office actions • 3 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| No statute on record | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAU, JASON | 1 | 53.9% | +14.4% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 67.7% | +39.0% |
| PILCHER, JONATHAN L | 1 | 63.7% | +45.2% |
| MARTIN, PAUL C | 1 | 42.0% | +21.7% |
| GUINO-O UZZLE, MARITES A | 1 | 69.8% | +16.6% |
| ESSEX, LAURA ANN | 1 | 59.6% | +33.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17779213 | METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY | GUINO-O UZZLE, MARITES A | 120d overdue |
| 18791873 | Alignment of A Disposable For A Spray Drying Plasma System | LAU, JASON | 43d overdue |
| 17945126 | Pretreatment Of Plasma For Spray Drying And Storage | MARTIN, PAUL C | 32d overdue |
| 18467074 | Pretreatment Of Plasma For Spray Drying And Storage | PILCHER, JONATHAN L | 16d |
| 18467089 | Blood Plasma Product | VIJAYARAGHAVAN, JAGAMYA NMN | 26d |
| 17769916 | Extended Half-life G-CSF and GM-CSF Vitamin D Conjugates | ESSEX, LAURA ANN | 34d |
| Client (Assignee) | Pending OAs |
|---|---|
| Velico Medical, Inc. | 4 |
| Cemgreen APS | 1 |
| Ramea LLC | 1 |
| Art Unit | Apps |
|---|---|
| 3762 | 1 |
| 1633 | 1 |
| 1772 | 1 |
| 1653 | 1 |
| 1731 | 1 |
| 1675 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18791873 | Alignment of A Disposable For A Spray Drying Plasma System | Velico Medical, Inc. | LAU, JASON | 3762 | Other | Non-Final OA | 43d overdue | Pending | Aug 01, 2024 |
| 18467089 | Blood Plasma Product | Velico Medical, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | Other | Non-Final OA | 26d | Pending | Sep 14, 2023 |
| 18467074 | Pretreatment Of Plasma For Spray Drying And Storage | Velico Medical, Inc. | PILCHER, JONATHAN L | 1772 | Other | Non-Final OA | 16d | Pending | Sep 14, 2023 |
| 17945126 | Pretreatment Of Plasma For Spray Drying And Storage | Velico Medical, Inc. | MARTIN, PAUL C | 1653 | Other | Non-Final OA | 32d overdue | Pending | Sep 15, 2022 |
| 17779213 | METHODS FOR PRODUCING CEMENT COMPRISING A SUPPLEMENTARY CEMENTITIOUS MATERIAL, AND CEMENT OBTAINABLE THEREBY | Cemgreen Aps | GUINO-O UZZLE, MARITES A | 1731 | §103 | Final Rejection | 120d overdue | Pending | May 24, 2022 |
| 17769916 | Extended Half-life G-CSF and GM-CSF Vitamin D Conjugates | Ramea LLC | ESSEX, LAURA ANN | 1675 | §103 | Non-Final OA | 34d | Pending | Apr 18, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial